Boxer-Capital-Management

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "NUVL",
  "RVMD",
  "ORIC",
  "TIL",
  "APLS",
  "ANAB",
  "TNGX",
  "NRIX",
  "KYMR",
  "REPL",
  "LEGN",
  "PRTA",
  "AMLX",
  "PRLD",
  null,
  null,
  "RNA",
  "SLDB",
  "QURE",
  "BOLD",
  null,
  "ELVN",
  "KOD",
  "XENE",
  null,
  "DAWN",
  "DNLI"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 28
Total Value: 332470540
Accession Number: 0002018299-25-000002
Form Type: 13F-HR
CIK: boxer-capital-management
Manager Name: Boxer-Capital-Management

Data Enrichment

86% identified

24 identified4 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

28 positions • $332.5M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 2

Sort by:

Revolution Medicines, Inc.

RVMD|76155X100

Shares:1.3M

Value:$46.6M

% of Portfolio:14.0% ($46.6M/$332.5M)

Nuvalent, Inc.

NUVL|670703107

Shares:450.0K

Value:$31.9M

% of Portfolio:9.6% ($31.9M/$332.5M)

Merus N.V.

MRUS|N5749R100

Shares:700.0K

Value:$29.5M

% of Portfolio:8.9% ($29.5M/$332.5M)

Avidity Biosciences, Inc.

RNA|05370A108

Shares:865.0K

Value:$25.5M

% of Portfolio:7.7% ($25.5M/$332.5M)

ANAPTYSBIO, INC

ANAB|032724106

Shares:1.3M

Value:$24.2M

% of Portfolio:7.3% ($24.2M/$332.5M)

Xenon Pharmaceuticals Inc.

XENE|98420N105

Shares:600.0K

Value:$20.1M

% of Portfolio:6.1% ($20.1M/$332.5M)

Replimune Group, Inc.

REPL|76029N106

Shares:1.8M

Value:$17.5M

% of Portfolio:5.3% ($17.5M/$332.5M)

Apellis Pharmaceuticals, Inc.

APLS|03753U106

Shares:713.0K

Value:$15.6M

% of Portfolio:4.7% ($15.6M/$332.5M)

16934W106

Shares:1.8M

Value:$15.4M

% of Portfolio:4.6% ($15.4M/$332.5M)

Tango Therapeutics, Inc.

TNGX|87583X109

Shares:10.4M

Value:$14.2M

% of Portfolio:4.3% ($14.2M/$332.5M)

Enliven Therapeutics, Inc.

ELVN|29337E102

Shares:671.4K

Value:$13.2M

% of Portfolio:4.0% ($13.2M/$332.5M)

Oric Pharmaceuticals, Inc.

ORIC|68622P109

Shares:1.7M

Value:$9.7M

% of Portfolio:2.9% ($9.7M/$332.5M)

Day One Biopharmaceuticals, Inc.

DAWN|23954D109

Shares:1.2M

Value:$9.4M

% of Portfolio:2.8% ($9.4M/$332.5M)

Kymera Therapeutics, Inc.

KYMR|501575104

Shares:325.0K

Value:$8.9M

% of Portfolio:2.7% ($8.9M/$332.5M)

PROTHENA CORP PUBLIC LTD CO

PRTA|G72800108

Shares:690.0K

Value:$8.5M

% of Portfolio:2.6% ($8.5M/$332.5M)

uniQure N.V.

QURE|N90064101

Shares:750.0K

Value:$8.0M

% of Portfolio:2.4% ($8.0M/$332.5M)

Legend Biotech Corp

LEGN|52490G102

Shares:200.0K

Value:$6.8M

% of Portfolio:2.0% ($6.8M/$332.5M)

Nurix Therapeutics, Inc.

NRIX|67080M103

Shares:563.1K

Value:$6.7M

% of Portfolio:2.0% ($6.7M/$332.5M)

Amylyx Pharmaceuticals, Inc.

AMLX|03237H101

Shares:1.8M

Value:$6.2M

% of Portfolio:1.9% ($6.2M/$332.5M)

Solid Biosciences Inc.

SLDB|83422E204

Shares:1.2M

Value:$4.6M

% of Portfolio:1.4% ($4.6M/$332.5M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Revolution Medicines, Inc.(RVMDcusip76155X100)	1.3M	QoQ -69.20% (-3.0M) YoY-	All Managers (Combined)	$46.6M	14.0% ($46.6M/$332.5M)	QoQ -75.10% (-$140.6M) YoY-
Nuvalent, Inc.(NUVLcusip670703107)	450.0K	QoQ -59.82% (-670.2K) YoY-	All Managers (Combined)	$31.9M	9.6% ($31.9M/$332.5M)	QoQ -63.60% (-$55.8M) YoY-
Merus N.V.(MRUScusipN5749R100)	700.0K	QoQ -63.15% (-1.2M) YoY-	All Managers (Combined)	$29.5M	8.9% ($29.5M/$332.5M)	QoQ -63.12% (-$50.4M) YoY-
Avidity Biosciences, Inc.(RNAcusip05370A108)	865.0K	QoQ -49.92% (-862.4K) YoY-	All Managers (Combined)	$25.5M	7.7% ($25.5M/$332.5M)	QoQ -49.16% (-$24.7M) YoY-
ANAPTYSBIO, INC(ANABcusip032724106)	1.3M	QoQ 0.00% (+0) YoY-	All Managers (Combined)	$24.2M	7.3% ($24.2M/$332.5M)	QoQ +40.40% (+$7.0M) YoY-
Xenon Pharmaceuticals Inc.(XENEcusip98420N105)	600.0K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$20.1M	6.1% ($20.1M/$332.5M)	QoQ -14.41% (-$3.4M) YoY-
Replimune Group, Inc.(REPLcusip76029N106)	1.8M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$17.5M	5.3% ($17.5M/$332.5M)	QoQ -19.48% (-$4.2M) YoY-
Apellis Pharmaceuticals, Inc.(APLScusip03753U106)	713.0K	QoQ -50.00% (-713.0K) YoY-	All Managers (Combined)	$15.6M	4.7% ($15.6M/$332.5M)	QoQ -65.73% (-$29.9M) YoY-
(cusip16934W106)✕	1.8M	QoQ -12.13% (-250.0K) YoY-	All Managers (Combined)	$15.4M	4.6% ($15.4M/$332.5M)	QoQ +114.86% (-$8.2M) YoY-
Tango Therapeutics, Inc.(TNGXcusip87583X109)	10.4M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$14.2M	4.3% ($14.2M/$332.5M)	QoQ -55.66% (-$17.9M) YoY-
Enliven Therapeutics, Inc.(ELVNcusip29337E102)	671.4K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$13.2M	4.0% ($13.2M/$332.5M)	QoQ -12.53% (-$1.9M) YoY-
Oric Pharmaceuticals, Inc.(ORICcusip68622P109)	1.7M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$9.7M	2.9% ($9.7M/$332.5M)	QoQ -30.85% (-$4.3M) YoY-
Day One Biopharmaceuticals, Inc.(DAWNcusip23954D109)	1.2M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$9.4M	2.8% ($9.4M/$332.5M)	QoQ -37.41% (-$5.6M) YoY-
Kymera Therapeutics, Inc.(KYMRcusip501575104)	325.0K	QoQ -23.52% (-100.0K) YoY-	All Managers (Combined)	$8.9M	2.7% ($8.9M/$332.5M)	QoQ -47.97% (-$8.2M) YoY-
PROTHENA CORP PUBLIC LTD CO(PRTAcusipG72800108)	690.0K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$8.5M	2.6% ($8.5M/$332.5M)	QoQ -10.64% (-$1.0M) YoY-
uniQure N.V.(QUREcusipN90064101)	750.0K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$8.0M	2.4% ($8.0M/$332.5M)	QoQ -39.97% (-$5.3M) YoY-
Legend Biotech Corp(LEGNcusip52490G102)	200.0K	QoQ -71.42% (-500.0K) YoY-	All Managers (Combined)	$6.8M	2.0% ($6.8M/$332.5M)	QoQ -70.20% (-$16.0M) YoY-
Nurix Therapeutics, Inc.(NRIXcusip67080M103)	563.1K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$6.7M	2.0% ($6.7M/$332.5M)	QoQ -36.94% (-$3.9M) YoY-
Amylyx Pharmaceuticals, Inc.(AMLXcusip03237H101)	1.8M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$6.2M	1.9% ($6.2M/$332.5M)	QoQ -6.34% (-$420.0K) YoY-
Solid Biosciences Inc.(SLDBcusip83422E204)	1.2M	QoQ NEW(+1.2M) YoY-	All Managers (Combined)	$4.6M	1.4% ($4.6M/$332.5M)	QoQ NEW(+$4.6M) YoY-